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Abstract
The aim of our study was to assess the clinical effectiveness of topical adipose derived stem cell (ADSC)
treatment in laser induced corneal wounds in mice by comparing epithelial repair, inflammation, and
histological analysis between treatment arms. Corneal lesions were performed on both eyes of 40 mice by
laser induced photorefractive keratectomy. All eyes were treated with topical azythromycin bid for three
days. Mice were divided in three treatment groups (n = 20), which included: control, stem cells and basic
serum; which received topical treatment three times daily for five consecutive days. Biomicroscope
assessments and digital imaging were performed by two masked graders at 30, 54, 78, 100, and 172 h to
analyze extent of fluorescein positive epithelial defect, corneal inflammation, etc. Immunohistochemical
techniques were used in fixed eyes to assess corneal repair markers Ki67, α Smooth Muscle Actin (α-
SMA) and E-Cadherin. The fluorescein positive corneal lesion areas were significantly smaller in the stem
cells group on days 1 (p < 0.05), 2 (p < 0.02) and 3. The stem cell treated group had slightly better and
faster re-epithelization than the serum treated group in the initial phases. Comparative histological data
showed signs of earlier and better corneal repair in epithelium and stromal layers in stem cell treated eyes,
which showed more epithelial layers and enhanced wound healing performance of Ki67, E-Cadherin, and
α-SMA. Our study shows the potential clinical and histological advantages in the topical ADSC treatment
for corneal lesions in mice.
Keywords: adipose derived stem cells, corneal wound healing, stem cell therapy, lipoaspirate, corneal re-
epithelization
1. Introduction
The cornea provides a protective barrier and clear optical pathway for the visual system. This avascular
and transparent structure is composed of three layers, which include the outer most non-keratinized
stratified epithelium, stroma, and single-layered endothelium. Most corneal diseases and trauma involve
the epithelium and stroma and include immune disorders, chronic inflammation, infection, iatrogenic
procedures (i.e., laser refractive surgery), etc. These ocular disorders tend to cause severe inflammation,
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persistent epithelium defects, neovascularization, conjunctivalization, persistent corneal opacities, and
scarring, which can all lead to permanent vision loss [1,2,3].
The most common intervention for restoring corneal clarity and function is full thickness penetrating or
lamellar keratoplasty. However, there are great limitations related to little availability of donor tissue and
costs and complications related to surgery (i.e., graft failure, chronic inflammation, numerous follow-up,
etc.). Alternative surgical techniques include amniotic membrane transplantation and conjunctival limbal
autograft from the healthy fellow eye, but surgical outcomes and limitations are similar to keratoplasty [1].
Studies have shown that autologous serum [4] autologous plasma rich in growth factors [5,6] and other
novel topical treatments [7,8] can be beneficial in patients with various ocular surface disorders due to
inflammation, severe dryness, and persistent epithelial defects [4,5,6]. However, long-term clinical
efficacy multicenter data and standardized preparation protocols are lacking. Moreover, therapeutic effects
tend to be superficial, limiting and symptomatic involving the corneal epithelial and not directed on lesion
induced stromal scarring and damage.
In the past decade, stem cell therapy has been proposed in almost every branch of medicine, ranging from
cardiology, neurology, plastic surgery, dentistry, etc. [9,10,11,12] Similar to bone marrow derived stem
cells, numerous studies have shown that adipose derived stem cells (ADSC) are pluripotent and have the
capability of differentiating into multiple mesodermal cell lineages expressing specific markers and
proteins [12,13,14]. The interest in ADSC has greatly increased considering that it is easy to obtain large
quantities of autologous tissue in a rapid minimally invasive liposuction procedure that requires only local
anesthesia. Moreover, ADSC are extremely more abundant in adipose tissue than MSC in bone marrow
[15].
Numerous studies based on ADSC obtained from processed human lipoaspirate to treat corneal lesions in
various animal models have shown stem cells to be able to differentiate and produce corneal specific
proteins, thus enhancing wound healing and maintaining transparency [16], while providing inhibition of
inflammation [3] and angiogenesis [2]. ADSC can be placed in corneal stromal pockets. However, surgical
manipulation of cells and of the host cornea can be potentially damaging and may not be of potential
clinical use in a clinical setting.
Topical stem cell therapy may be of potential clinical use considering that ADSC are abundant, cost
efficient, multipotent, non-invasive, and beneficial in various phases of wound healing including cellular
remodeling, changes to tear composition, cell migration, proliferation, epithelial reattachment, and stromal
remodeling. Our previous study reported the topical use of ADSC in chemically induced corneal lesions in
rats [17]. These preliminary results showed that stem cell treated eyes had significantly smaller epithelial
defects at each time point, with better and faster re-epithelization and less inflammatory response
compared to other treatment arms. The ADSC group seemed to show improved corneal wound healing.
However, a small number of animals with chemically induced lesions in a brief time were considered in
the treatment and in the clinical assessment to provide a semi-quantitative assessment of data. The purpose
of our current study was to assess a greater number of eyes over a longer time period using a reproducible
laser-induced corneal wound in mice in addition to provide a comparison of epithelial repair, stromal haze,
inflammation, and quantitative histological analysis between treatment groups.
2. Material and Methods
2.1. Animals
Forty black male mice C57BL/6 (30–40 g) purchased from Charles River Laboratories (Barcelona, Spain)
were used in the experiments. Animals were housed with a 12-h light–dark cycle with ad libitum access to
food and water. Animal care and experiments were carried out in accordance with the guidelines of the
Spanish Ministry of Health for Animal Care (RD 53/2013) and European Commissions (2003/65/EC).
Prior to induction of lesion and treatments, mice were anesthetized by intraperitoneal injection of 80
mg/kg ketamine hydrochloride (Imalgène 500, Merial, Lyon, France) and 5 mg/kg xylazine hydrochloride
(Rompun, Bayer HealthCare, Kiel, Germany). Topical anesthesia was induced by 0.4% oxibuprocain eye
drops (Novesina, Novartis, Varese, Italy). Animals were euthanized with an overdose of sodium
pentobarbital (Dolethal, Vétoquinol, Lure, France) and verified by cervical dislocation.
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2.2. Isolation and Preparation of Adipose Derived Stem Cells
Human subcutaneous abdominal adipose tissue was obtained from healthy patients (aged 35–64 years)
undergoing elective lipoaspiration surgery with informed oral and written consent under a protocol
approved by the Institutional Review Board (IRB) of the University of Udine, in accordance with the
guidelines of the Tenets of the Declaration of Helsinki. Patients were screened and resulted negative for
HIV, hepatitis B and C virus, and syphilis.
Isolation, preparation, flow cytometry, immunofluorescence, and multilineage differentiation of ADSC
have been reported in our previous studies [12,17,18].
For the in vivo experiment, we employed ADSC obtained from a 35 year old female patient, at the third
passage in culture, in their undifferentiated state.
2.3. Blood Serum
Human serum was prepared in accordance to the Azienda Ospedaliero Universitaria Santa Maria della
Misericordia protocol [17]. In brief, 500 mL of whole blood from one healthy young male donor (45 years
old) was collected into sterile 9 mL tubes after written informed consent. The patient was screened and
resulted negative for HIV, hepatitis B and C virus, and syphilis. The containers were left standing in an
upright position to ensure clotting for at least 30 min at room temperature, then centrifuged at 2000× g for
10 min. The supernatant serum was removed under sterile conditions in a laminar flow hood with sterile
disposable syringes. The vials were frozen and left to thaw for 24 h before treatment. In accordance to our
hospital protocols on clinical treatment for severe dry eye syndrome, we used undiluted whole serum.
2.4. Laser Induced Corneal Wound
After intraperitoneal and topical anesthesia, corneal lesions were performed on both eyes of 40 mice by
laser induced photorefractive keratectomy (PRK) [19]. To induce the epithelial and stromal laser lesion,
each eye was placed under a Wavelight Allegretto Wave PR-020407 excimer laser (Wavelight GmbH,
Alcon, Erlangen, Germany). The PRK ablation parameters included a diameter of 2 mm to the central
optic zone and a total depth of 45 µm to induce a uniform lesion affecting both epithelium and stroma. The
laser began nasally and progressed temporally.
2.5. Treatment Regimen
All animals were treated with topical eye drops of azythromycin 1.5% (Azyter, Laboratoires Thea,
Clemrmont-Ferrand, France) for antimicrobial prophylaxis two times daily for three days after lesion [19].
Eighty eyes of 40 mice were divided in four treatment groups (n = 20 eyes per group), which included
control, stem cells, basic serum, and plasma rich in growth factor (PGRF). Data from the PGRF (not
shown) were intended and collected for a different ongoing study. Control eyes received only antibiotic
eye drops. The other 3 groups also received topical treatment applied three times a day for five consecutive
days. Topical drops were administered with a delay of at least 5 min between applications for multiple
treatment regimens. Stem cell topical eye drops were prepared daily with 1 × 10  cells suspended in 25 µL
HBSS/treatment [16]. The basic serum group received topical application of 25 µL of 100% human serum.
2.6. Ocular Surface Evaluation
Upon topical anesthesia, each treated eye was examined with a stereo biomicroscope before application of
topical treatment at 30, 54, 78, 100, and 172 h after lesion (also referred to in this study as day 1, 2, 3, 4,
and 7, respectively). This was done at each time point to assess corneal inflammation, opacities, and other
anterior surface complications (i.e., infection, perforation, etc.). Fluorescein sodium solution (Colircusí
Fluoresceína, Alcon Cusí, Barcelona, Spain) was used to evaluate the degree of the corneal epithelial
defect. Each animal’s anterior segment was photographed with a Leica S6D stereo microscope (6.3:1 zoom
and 15.0× magnification) equipped with a Leica EC3 digital camera (Leica Microsystems, Wetzlar,
Germany) with and without fluorescein at each clinical assessment. The defect area was determined by the
fluorescein positive remaining area under blue light (1 mm = 240 pixels) using ImageJ 1.45a software
(National Institutes of Health, Bethesda, MD, USA). Based on anterior segment visualization of pupil, iris
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and the presence of corneal vessels with stereo biomicroscopy at each examination time point. The
analysis was performed independently by two masked graders.
2.7. Histological Examination
Eyes were fixed in Somogyi’s fixative without glutaraldehyde, rapidly frozen in liquid nitrogen, and
preserved in OCT compound. The specimens were cut into 5 µm-thick tissue sections with a cryostat and
subjected to immunofluorescence techniques. Sections were examined under fluorescence microscopy.
With regards to the 33 mice of the 40 animals (66 eyes) included in the analysis, 32 eyes of 16 animals
were enucleated after 78 h (day 3), while the remaining 34 eyes of 17 mice were enucleated at the end of
the study at 172 h (day 7) post-lesion. The details regarding the histological preparation and assessment are
reported in the Appendix section.
For immunofluorescence analysis we used antibodies to Ki67 (proliferation; 1:500; Abcam, Cambridge,
UK), α-SMA (myofibroblast transformation; 1:200; Abcam), E-cadherin (assembly of epithelial cells;
1:200; Santa Cruz Biotechnology, Santa Cruz, CA, USA). Further details regarding the antibodies used in
our study have been reported in the Appendix section under the heading “Histological examination” on
page 14, lines 532–575.
3. Statistical Analysis
Normality of the data distribution was assessed with the Kolmogorov-Smirnov test. Data were expressed
as median ± standard deviation. Differences of the data amongst groups were analyzed with SPSS 20.0
(SPSS Inc., Chicago, IL, USA) for Windows program using Kruskal-Wallis and Friedman test. Multiple
comparisons were performed with Dunnett’s test. A p value of < 0.05 was considered to be statistically
significant.
4. Results
4.1. Clinical Outcomes
The PRK lesion was performed uneventfully in all mice eyes. Immediately after the laser ablation, the
treated areas showed a whitish uniform, hazy appearance. There were no signs of neovascularization or
perforation in all eyes. Three animals (#24, 29 & 39) died of hypothermia at 30 h after anesthesia, and four
animals (#6, 12, 38 & 28) were found dead in the cages (probably due to natural causes) before the
endpoint on the 7th day. A total of 33 of 40 animals (66 eyes) were considered in the statistical analysis: 18
stem cell treated eyes, 15 basic serum eyes, and 17 control eyes. Of these, 16 (32 eyes) underwent
treatment for three days and sacrificed at 78 h, and the remaining 17 animals (34 eyes) completed the five-
day treatment regimen and then sacrificed at 172 h.
Partial re-epithelization was seen in all mice eyes at the first time point at 30 h. All eyes were completely
re-epithelized by 100 h (Table 1a & Figure 1). On the first day, the fluorescein positive corneal lesion area
was significantly smaller in the stem cells groups than the control eyes (Table 1a & Figure 1 & Figure 2; p
< 0.05); on the second day, it was significantly larger in the controls, yet comparable between stem cell
and serum treatment groups (Table 1a & Figure 1 & Figure 2; p < 0.02). No differences were found
amongst groups on the other days.
Inter-individual differences were seen in the mice, even amongst eyes with the same treatment. To limit
this variability, several mice were treated with stem cells on the right eye and control on the left. The stem
cell treated eyes tended to show faster wound healing with smaller defect areas at most of the earlier time
points in all these eyes. Figure 3 shows examples of the fluorescein positive areas at each time point for
these eyes.
Qualitative histology assessments were performed in 27 eyes of 15 mice eyes at 78 h (day 3) after lesion
(10 control, 8 stem, 9 basic serum) and 28 eyes of 15 mice eyes at 172 h (day 7) after lesion (8 control, 10
stem, 10 basic serum).
4.2. Histological Outcomes
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With regards to the epithelium histological assessment after three days, the stem cell group showed a
slightly increased number of epithelial cell layers (Figure 4 and Figure 5). There were three layers of
epithelial cells in the peripheral region of the damaged cornea, while about four layers of cells in the
central post-injured area. The number of Ki67 cells in the peripheral epithelium was similar amongst
groups, however, the stem cells treated eyes showed less of these actively replicating cells in the
epithelium, yet more in the stroma underlying the lesion when compared with the other groups (Table 1b).
E-Cadherin protein accumulated in the basal cell layer of the epithelium and was present in the cytoplasm (
Figure 5). This localization suggests that the epithelium was not stabilized and was still involved in a
reorganization process [20,21,22]. In the control eyes, there were only three layers of epithelial cells and a
slightly less number of Ki67+ cells in the peripheral epithelium (Table 1b). The E-Cadherin pattern was
similar to that described in the stem cell treated eyes (Figure 5). In the basic serum eyes, there were 5 to 6
layers of epithelial cells and a higher number of Ki67+ cells across the extension of the epithelium. The E-
Cadherin pattern was diffuse in the basal cells of the epithelium, similar to the stain observed in the other
groups.
With regards to the stromal histology at three days, all eyes showed E-Cadherin-positive cells indicating
the presence of migratory elements in the stroma, probably involved in reparative processes. Moreover, a
small number of myofibroblasts (α-SMA positive profiles) were found in the stromal under the epithelium
in the lesion area. These myofibroblasts were more frequent in the control corneas when compared to those
found in the basic serum treated eyes. These myofibroblasts were scarce and not frequently seen in the
stem cell treated eyes (Figure 6a).
After seven days of lesion, the stem cell treated eyes showed epithelium that was similar to uninjured
epithelium, composed of 4 to 5 layers of uniform and perfectly structured epithelial cells (Figure 6b). E-
Cadherin protein was localized at the periphery of epithelial cells, similar to what is normally found in
healthy uninjured epithelium, thus indicative of a stabilization of the corneal regenerating epithelium [22].
The number and distribution of proliferating Ki67 positive cells were similar to that measured in normal
mouse corneal epithelium. The control eyes showed the same structure of epithelium; however, there
appeared to be at least one additional layer and more Ki67 positive cells (Table 1b, Figure 7). The basic
serum treated eyes showed about 5 to 6 layers in the epithelium and a higher number of Ki67 positive cells
(Table 1b).
The stromal histology after seven days (Figure 7) showed that the stem cell treated had little or no E-
Cadherin positive elements in the stroma. The E-Cadherin positive elements, however, appeared to be
abundant in the basic serum treated eyes and control eyes, which can be indicative of migratory events in
the stroma. After seven days, there was a significant reduction in the quantity of α-SMA  myofibroblasts
in stem cell treated group (4.09 ± 0.48 cells) compared to control (10.85 ± 0.76 cells; p < 0.001) and, to a
lesser extent, compared to basic serum group (6.27 ± 0.65 cells; p < 0.05).
5. Discussion
Similar to our previous studies, ADSC were obtained from human adipose tissue aspirates following a
protocol optimized for the isolation and in vitro expansion of human multipotent adult stem cells [12,17].
ADSC expressed the pluripotent state-specific transcription factors Oct-4, Nanog and Sox 2 [12,17].
ADSC highly expressed CD90, CD105, CD73, however, were mainly negative for the hematopoietic
markers CD34 and CD45. These cells displayed multipotency. Further details regarding ADSC are
reported in the Appendix section. Our results show that ADSC seem to enhance corneal wound healing
induced by laser ablation when compared to traditional topical therapy.
In accordance to our previous study based on chemical induced corneal lesions in rats [17], the percent of
epithelium fluorescein positive damage in eyes treated with stem cells (with or without serum) was smaller
at each time point, which was statistically significant when compared to the control mice eyes (Table 1a).
Stem cell treated eyes reached complete epithelium closure faster than the control eyes (Figure 1). The
results showed statistically smaller lesions after day 1 in the stem cell group, which was comparable to the
basic serum treated eyes but less than that observed in the control group on days 2 and 3 (Table 1a, 
Figure 1 & Figure 2).
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With regards to the mice histological data, the presence of more layers of epithelial cells in the early stages
of repair in the stem cell treated group compared to the control eyes could be related to an improvement in
the re-epithelization of the corneal surface after injury. The epithelium under the lesion had a smaller
number of Ki67 actively replicating cells in the stem cell eyes, yet the stroma appeared to have
significantly more than the other groups (Table 1b), which may be indicative of earlier stromal repair and
post-mitotic epithelium layer reformation in this group at three days. Although these epithelial layers
covered the entire corneal surface, these cells appeared to be undergoing reorganization during the initial
period after lesion, as deduced by the elevated rate of proliferation of basal epithelial cells in the central
region of the cornea and the localization pattern of E-Cadherin protein in the epithelium [21,22]. E-
Cadherin did not appear to be distributed in the periphery of epithelial cells, as expected in stable
uninjured epithelium; however, it mostly accumulated in the cytoplasm of basal epithelial cells. This
location of E-Cadherin suggested an ongoing reorganization process of the epithelial layers [20,21,22].
Although all eyes exhibited complete re-epithelization macroscopically after seven days, the histological
evaluation showed that the epithelium of individuals treated with stem cell contained four or five layers,
which is the number of layers normally found in uninjured mouse corneal epithelium. The number of
dividing cells (Ki67+) in the central region was very low, which resembled a normal cornea with a well-
established epithelium structure. The cytoarchitecture of the epithelium was that of a normal epithelium,
showing cuboidal cells in the basal layer, with a few layers of low cuboidal cells positioned on top,
followed by 1–2 outer sheets of flattened wing cells. E-Cadherin appeared to be located externally
bordering epithelial cells and was observed in all layers. In comparison, the control eyes had at least one
additional layer of epithelial cells, which may be indicative of an incomplete or altered repair process. The
eyes treated with the blood derivatives PRGF (data not shown) and basic serum showed five to six layers
of epithelial cells, which may be indicative of an ongoing re-epithelization and possible delay in the
cessation of cell proliferation in the central region of the cornea, as seen with the presence of numerous
Ki67+ cells.
The stroma of mice eyes treated with stem cells had a notably lower density of myofibroblasts (α-SMA
elements) compared with control and basic serum eyes at both three and seven days, which may be related
to the slightly better corneal transparency and lower haze in the stem cell eyes (based on a qualitative
comparative analysis between groups, data not shown) [23,24,25,26,27]. E-Cadherin+ cells were not found
in the stroma of stem cell treated eyes and controls after seven days, yet were abundant in the PRGF and
serum treated eyes. The lack of E-Cadherin+ cells can be indicative of a stabilization of the stromal
cytoarchitectural organization. In contrast, the stroma of the blood derived treated groups continued to
have reorganizations events and mobility of cellular elements in the stroma. The physiological roles of
ADSC are diverse and promising in tissue regeneration and wound healing [13,14,28]. ADSC obtained
from lipoaspirate have been shown to meet the minimal set of 4 criteria proposed by the Mesenchymal and
Tissue Stem Cell Committee of the International Society for Cellular therapy [29] used to define functional
human MSC [12,13,18,30] In addition to their extensive proliferation potential and multilineage
differentiation, ADSC can interact and affect the immune system response to injury, by the down-
regulation of proinflammatory factors and production of several trophic factors [23,31,32]. Several reports
have shown the immunoregulatory properties of MSC, which include the inhibition of T-cells [33],
increase in tumor necrosis factor (TNF) from dentritic cells [34], increase in regulatory T-cells [34], block
of antigen producing cell maturation [35], increase in immunosuppressive cytokine interleukin (IL)-10 and
TNF-β and decrease in IL-2 [2]. The endocrine function of adipose tissue is evident through the secretion
of numerous growth factors (GF) like epidermal GF, vascular endothelial GF, basic fibroblast GF,
keratinocyte GF, and platelet-derived GF [30].
There are limited studies in current literature regarding the use of ADSC in ocular surface and stromal
wound healing [36,37,38,39]. Arnalich-Montiel showed that human ADSC could regenerate into corneal
tissue in situ when inserted in a laser induced intrastromal corneal pocket in a rabbit model [16]. The
transplanted cells appeared to be safe, maintained corneal transparency and caused no immune reaction
[40]. The transplanted multipotent stem cells acquired similar characteristics to keratocytes [41]. Studies
have shown that topical application of stem cells are easy, and may prove to be clinically acceptable and
effective in acute phases [42,43].
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Appendix A.1. Animals
Appendix A.2. Histological Examination
The presence of corneal limbal stem cells (LSC) was first discovered in the late 1980’s [44]. These slow-
cycling subpopulation of epithelial basal cells located in the peripheral limbus of the cornea were found to
have a substantial proliferating capacity. Autologous and allogenic LSC transplants are surgical option
[45], however, donor tissues are limited and autologous transplants may give rise to iatrogenic damage to
the healthy fellow eye or at times the fellow eye is not healthy. Recent studies have reported the presence
of MSC in the human limbal biopsies having similar immunophenotype and immunocytochemical markers
to those present in bone marrow derived MSC [46].
With regards to the clinical use of ADSC for ocular surface wounds in humans, only a single case report
has been published by a group in Greece [47]. A young male underwent an experimental treatment
involving topical application of autologous ADSC, which was obtained by lipoaspiration of subcutaneous
adipose tissue from the lumbar area. The ADSC were isolated from the lipoaspirate and applied to the
bottom of the ulcer, followed by closure of the lid with a pressure eye patch for 24 h. Corneal healing was
observed after 11 days. At six months after treatment, the patient still did not require surgery, visual acuity
was improved to 20/40, central corneal thickness was 476 µm, and corneal transparency improved with
mild residual anterior stromal opacification.
6. Conclusions
Our mice experiments based on a laser-induced lesion confirmed that stem cell treated eyes had
significantly smaller epithelial defects at each time point, with better and faster re-epithelization and less
inflammatory response compared to other treatment arms, which was already reported in our preliminary
rat study based on a chemical induced lesion model. Literature in this field is limiting, thus additional
studies using a different animal model and different type of lesion was proposed in this study to confirm
preliminary experiments and report additional data. Our mice experiments were based on a larger group of
animals assessed for a longer follow-up compared to our preliminary rat studies. Our study adds to the
limiting literature currently available in this field by confirming the biosafety, immunogenicity, and
potential clinical and histological advantages in using this mode of stem cell treatment. Future studies
involve the assessment of epithelial recovery, inflammation, corneal haze, and quantitative histological
assessments compared in different treatment arms. Although the exact mechanisms are not known, these
cells are multipotent and have the potential to differentiate toward a keratocyte stromal lineage and
therefore theoretically appear to be a promising therapeutic alternative and advantageous compared to
treatments currently utilized in clinical practice. Most studies have shown ADSC to be promising in
animal models, which can serve as a great stepping stone in addressing the topical therapeutic use of stem
cells in humans.
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Appendix A
Our decision to use both eyes was not solely based on a cost issue but based on a
similar experimental model used in our previous study published in Current Eye Research [17]. This was
done in accordance to the 3R statement of the European Community (reduce, replace, refine) that
encourages the use of fewer experimental animals, and to compare treatments on the same animals to
reduce inter-animal variability, thus both eyes were also used in the experiment. In addition, we obtained
the approval of the Animal Ethical Committee of the University of Oviedo (Spain).
Eyes were fixed in Somogyi’s fixative without glutaraldehyde
for 3 h, cryoprotected overnight in 30% sucrose solution, embedded in OCT compound and frozen in
liquid Nitrogen. The entire frozen eyeball was placed on a cryostat chunk and oriented to obtain
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Appendix A.3. Adipose-Derived Stem Cells (ADSC)
transversal sections of the cornea. Cryostat sections with a thickness of 5 µm were collected on Superfrost
microscope slides (Thermo Scientific, Rochester, NY, USA) and stored frozen.
For each eye, three selected histological sections in the central region of the injured cornea were chosen to
demonstrate each marker used to evaluate the quality of corneal repair, which included:
1. Polyclonal antibody against Ki67 produced in rabbit (Abcam, Cambridge, UK): This antibody is
present in the nuclei of actively dividing cells and can be used as a measure of the number of
proliferating cells in a repairing process [48].
2. Polyclonal antibody against α Smooth Muscle Actin (α-SMA) produced in rabbit (Abcam,
Cambridge, UK): The α-SMA presenting cells are identified as myofibroblast during the wound
healing process [24,25,49].
3. Polyclonal antibody against E-Cadherin produced in rabbit (Santa Cruz Biotechnology, Santa Cruz,
CA, USA): The E-Cadherin protein locates normally bordering epithelial cells, thus allowing a
visualization of the cytoarchitecture of a multilayered epithelium [20,21].
Fluorescent immunohistochemical techniques were used to assess these markers. Selected cryosections
were carefully thawed in a water bath; slides were placed in a humidity chamber and washed three times in
PBS (Phosphate Buffered Saline) with Triton X-100 (0.03%). A brief incubation with a blocking medium
(1% bovine serum albumin and 10% normal goat serum; Vector Laboratories, Burlingame, CA, USA) was
added to avoid nonspecific binding of the secondary antibody. The blocking medium was then removed by
washing the slides three times with PBS with Triton X-100 (0.03%). The sections were incubated
overnight at 4 °C with the appropriate primary antibody at a specific dilution (Anti-Ki67 at 1:500; Anti-
αSMA at 1:200; and, Anti-E-Cadherin at 1:100). Sections were then washed again three times in PBS and
incubated with a fluorescent secondary antibody (anti-rabbit Alexa Fluor 594 raised in goat, Molecular
Probes, Grand Island, NY, USA) in a dilution of 1:500 for 2 h at room temperature in the dark. Three
additional washes were then used to eliminate the excess of fluorescent antibody. Nuclei were
counterstained with 2 µg/mL 4′,6-diamidino-2-phenylindole dihydrochloride (DAPI; Molecular Probes,
Grand Island, NY, USA) for 10 min and slides were mounted with Dako fluorescence mounting medium
(Dako, Glostrup, Denmark) and coverslips. Slides were then identified and encoded with a numerical
system and stored at 4 °C.
The analysis of the wound healing parameters was performed on histological images using a Leica
DM6000 microscope equipped with epifluorescence using a 20× objective (numerical aperture 0.45) and
AF6000 software (Leica Microsystems, Wetzlar, Germany). Measurements were performed in a
semiautomated manner using ImageJ 1.45a software (National Institutes of Health, Bethesda, MD, USA).
Two independent masked observers performed the analysis. Data were collected and decoded, and
statistical analysis was performed using InStat 3.1a software (GraphPad Software Inc., La Jolla, CA,
USA).
Human subcutaneous abdominal adipose tissue was
obtained from thee healthy female patients (aged 35, 52, and 64 years) undergoing elective lipoaspiration
surgery. ADSC used in the treatment group, however, came from a single healthy donor (youngest female
aged 35 years) and were employed, at the third passage in culture, in their undifferentiated state. Cells
were characterized in accordance to the study reported by Domenis et al. in 2015 [29]. Specifically, cells
satisfied the minimal criteria of ISCT. Moreover, they were checked for additional markers, such as the
expression of pluripotent state-specific transcription factors. Although we are aware that a certain degree
of controversy surrounds this latter feature, Chih-Chien Tsai et al. [50] has shown that Oct-4 is not only
expressed but also required for MSC self-renewal. Additionally, other independent groups showed the
expression of these markers in MSC [51,52].
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Figure 1
Intragroup comparisons of median epithelium defect area over time for each treatment group in the mice eyes. * =
statistically significant difference between stem cells and control groups; ^ = statistically significant difference between
controls and the other groups.
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Figure 2
Box plots of median epithelium defect area over time at each time point for each treatment group in the mice eyes. * =
statistically significant difference between stem cells and control groups; ^ = statistically significant difference between
controls and the other groups.
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Figure 3
Fluorescein positive areas at each time for animals # 1, 2, 3, and 17. For intraindividual comparisons, the right eye (red
squares) of each mouse was treated with stem cells and the left eye (blue triangles) was treated with the control regimen.
The stem cell eyes tended to show better epithelial wound healing than the control eyes in the first three days with smaller
fluorescein areas and faster total re-epithelization.
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Figure 4
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Images of Ki67 positive cells (in red) in the central epithelium of wound healing corneas treated with adipose-derived
stem cells ADSC for three days (A) compared to the control eyes (B). Both groups showed a high number of proliferating
cells in the basal cell layer of the regenerating epithelium (arrows). Note a slightly higher level of organization in stem
cell treated cornea. Some proliferating cells could be found in the stroma (asterisks) (Scale bars: 40 µm).
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Figure 5
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Corneal epithelium wound healing after three days assessed with E-Cadherin immunostaining. (A) represents an eye
treated with ADSC. E-Cadherin (marked in red) appeared to be distributed in the basal cell layer of the epithelium and
accumulated in the cytoplasm. Elongated irregular processes could be seen in the stroma; some cells presented E Cadherin
staining; (B) represents a control eye, which showed a similar pattern of distribution of E Cadherin staining in the cornea.
Nuclei are counterstained with DAPI (in blue). Note the difference in the number of layers between stem cell treated
group and untreated corneas (Scale bar 40 µm).
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Figure 6
(a) ADSC treatment (A) seemed to retard the onset of myofibroblast appearance when compared to the controls eyes (B)
during the initial stages of the wound healing process (three days after injury). There tended to be scarce or no
myofibroblasts in the stroma in the ADSC treated eyes; only a diffuse staining for α-SMA (in red arrows) was visible in
the basal cells of the central epithelium (A). In contrast, several α-SMA  myofibroblasts (shown as elongated cells stained
in red asterisks) were present in the upper stroma of the control eyes (Scale bars: 40 µm). (b) E-Cadherin staining (in red)
7 days after injury. E-Cadherin appeared to be located bordering the epithelial cells and rarely accumulated in the
cytoplasm in the ADSC treated eyes (A). The control corneas showed a different staining pattern for E Cadherin, which
accumulated in the cytoplasm of the epithelial cells (B). A similar location of epithelial E-Cadherin was found in the basic
serum treated eyes, which tended to accumulate in the cytoplasm of the basal cells (C). There also appeared to be more E-
Cadherin  cells in the stroma of the basic serum treated eyes. (Scale bar 40 µm).
+
+
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Figure 7
Left panel shows examples of proliferative events in the central epithelium 7 days after injury. In the ADSC treated eyes
(A), there were scarce residual amounts of Ki67+ cells (in red, arrows), which can normally found in the epithelium
uninjured corneas. There were no proliferative elements found in the stroma. In contrast, the control eyes (B) showed
numerous Ki67 positive cells located both in the central epithelium (arrows) and stroma (asterisks). Right panel shows α-
SMA staining (in red) during corneal wound healing 7 days after injury. The ADSC eyes showed a very low number or
absence of myofibroblasts in the stroma ((C), asterisk). Control eyes exhibited strong staining to α-SMA in the upper
stroma with numerous filiform myofibroblasts ((D), asterisks). The basic serum treated eyes also showed a high number
of α-SMA+ myofibroblasts in the stroma ((E), asterisks). The epithelium showed a diffuse staining to α-SMA in all cases
(arrows), which varied and did not appear to be influenced by treatment (Scale bars: 20 µm).
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Table 1
(a) Median fluorescein positive corneal lesion area (mm ) in mice for each group over time. (b) Number
Ki67 cells in the peripheral and central post-lesion corneal epithelium and stroma in the different treatment
groups at day 3 and day 7 after lesion (mean of total number of cells in three sections per corneal sector).
(a)
Time after Lesion Controls Basic Serum Stem Cells p
Day (hours) (Median ± SE) (Median ± SE) (Median ± SE) Value *
Time after Lesion Controls Basic Serum Stem Cells p
Day (hours) (Median ± SE) (Median ± SE) (Median ± SE) Value *
Day 1 (30 h) 1.25 ± 0.80 0.90 ± 0.68 0.83 ± 0.42 0.048
Day 2 (54 h) 0.26 ± 0.39 0.07 ± 0.40 0.08 ± 0.20 0.018
Day 3 (78 h) 0.05 ± 0.29 0.04 ± 0.32 0.01 ± 0.14 0.127
Day 4 (100 h) 0.00 ± 0.05 0.00 ± 0.00 0.00 ± 0.03 0.202
Day 7 (172 h) 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 1.000
p value ^ 0.0001 0.0001 0.0001
* = Kruskal-Wallis test; ^ = Friedman test;  = significantly higher than stem cells group;  = significantly higher than the
other groups.
(b)
Group Number of Ki67 Cells ± Standard Deviation
Peripheral Epithelium Central Post-Lesion Epithelium Central Stroma
Three Days after Lesion
Control (n = 10) 112.25 ± 17.00 69.00 ± 8.00 7.00 ± 2.10
Stem (n = 8) 120.00 ± 8.90 37.30 ± 6.33 18.00 ± 4.43 
Basic serum (n = 9) 131.40 ± 9.77 72.30 ± 7.60 9.55 ± 2.89
p value ^ 0.027 0.0001 0.001
Seven Days after Lesion
Control (n = 8) 67.00 ± 7.89 24.00 ± 5.40 4.50 ± 1.66
Stem (n = 10) 61.00 ± 5.22 16.50 ± 2.88 1.33 ± 0.54 
Basic serum (n = 10) 65.50 ± 5.40 27.60 ± 5.74 4.30 ± 1.25
p value ^ 0.022 0.001 0.001
^ = Kruskal-Wallis test;  = significantly different than the other groups;  = significantly lower than the other groups;  =
significantly higher than the other groups.
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